A detailed history of Clarity Capital Partners LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Clarity Capital Partners LLC holds 2,495 shares of BSX stock, worth $215,667. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,495
Previous 2,737 8.84%
Holding current value
$215,667
Previous $211 Million 0.8%
% of portfolio
0.12%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$72.96 - $84.0 $17,656 - $20,328
-242 Reduced 8.84%
2,495 $209 Million
Q2 2024

Jul 30, 2024

BUY
$67.33 - $77.71 $184,282 - $212,692
2,737 New
2,737 $211 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $124B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Clarity Capital Partners LLC Portfolio

Follow Clarity Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarity Capital Partners LLC with notifications on news.